Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Neoplasm Metastasis 1 Lung Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1

Interventions

pembrolizumab 221 Carboplatin 214 Cisplatin 202 Paclitaxel 181 Gemcitabine 148 Docetaxel 126 Capecitabine 113 Cyclophosphamide 101 Pemetrexed 100 Dexamethasone 100 Specimen Handling 98 Oxaliplatin 96 Magnetic Resonance Spectroscopy 96 Radiotherapy 92 Doxorubicin 91 Fluorouracil 88 Bevacizumab 84 Leucovorin 73 Nivolumab 72 Rituximab 71 Vincristine 67 durvalumab 65 Lenalidomide 64 atezolizumab 61 Radiation 61 Irinotecan 61 Etoposide 60 130-nm albumin-bound paclitaxel 58 Prednisone 55 Letrozole 55

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × OGX-011 × 1 year × Clear all

NCT01630733 2026-04-15

ENSPIRIT

Achieve Life Sciences

Phase 3 Completed

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡